Abiraterone Acetate Tablet, Film Coated
Product Images NDC 82293-002

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Abiraterone Acetate (NDC 82293-002). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Novugen Pharma (usa) Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Figure 1 (Figure 1)

Figure 1 (Figure 1)
A survival curve graph showing % survival over time to death in months for Abiraterone Acetate versus Placebo. The x-axis represents time to death in months (0 to 21), and the y-axis represents % survival (0 to 100). The graph compares two groups with patient counts noted below the x-axis.*
FDA Label Image

Figure 2 (Figure 2)

Figure 2 (Figure 2)
A survival curve chart comparing the percentage of subjects without death over months from randomization for Abiraterone acetate versus placebo. The x-axis represents months from randomization (0 to 60), and the y-axis shows the percentage of subjects without death (0 to 100%). Two lines represent the survival rates for Abiraterone acetate and placebo groups, with sample sizes listed below the x-axis for each group at different time points.*
FDA Label Image

Figure 3 (Figure 3)

Figure 3 (Figure 3)
A Kaplan-Meier survival curve chart comparing the percentage of subjects without radiographic progression or death over time between Abiraterone acetate and placebo groups. The x-axis shows months from randomization (0 to 18), and the y-axis shows the percentage of subjects without radiographic progression or death (0% to 100%). The graph includes the number of subjects at risk at various time points for both groups.*
FDA Label Image

Figure 4 (Figure 4)

Figure 4 (Figure 4)
A Kaplan-Meier survival curve chart comparing the percentage survival of subjects without death over months from randomization between Abiraterone Acetate and placebo groups. The graph shows survival decreasing over time for both groups, with Abiraterone Acetate represented by a solid line and placebo by a dashed line. A table below the graph displays the number of subjects at risk at various time points for each group.*
FDA Label Image

Abiraterone Acetate Tablets 250 mg Bottle Label (Image250mg)

Abiraterone Acetate Tablets 250 mg Bottle Label (Image250mg)
Abiraterone Acetate Tablets, USP 250 mg film-coated tablets label from Novugen Pharma (USA) LLC. The label includes storage instructions, a warning for pregnant women, and states the package contains 120 tablets. It also advises to swallow whole tablets and not to crush or chew them. The product is made in France.*
FDA Label Image

Abiraterone Acetate Tablets 500 mg Bottle Label (Image500mg)

Abiraterone Acetate Tablets 500 mg Bottle Label (Image500mg)
Label for Abiraterone Acetate Tablets USP 500 mg, film-coated tablets in a bottle of 60 count. The label shows storage instructions, a handling warning for pregnant women, and advises swallowing tablets whole without crushing or chewing. Distributed by Novugen Pharma (USA) LLC, made in France.*
FDA Label Image

Abiraterone Acetate Structural Formula (Structure001)

Abiraterone Acetate Structural Formula (Structure001)
Chemical structure of abiraterone acetate, depicting its molecular arrangement including rings and functional groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.